BACKGROUND: Although adverse neuropsychological and neurological health effects are well known among workers with high manganese (Mn) exposures in mining, ore-processing and ferroalloy production, the risks among welders with lower exposures are less well understood. METHODS: Confined space welding in construction of a new span of the San Francisco-Oakland Bay Bridge without adequate protection was studied using a multidisciplinary method to identify the dose-effect relationship between adverse health effects and Mn in air or whole blood. Bridge welders (n = 43) with little or no personal protection equipment and exposed to a welding fume containing Mn, were administered neurological, neuropsychological, neurophysiological and pulmonary tests. Outcome variables were analysed in relation to whole blood Mn (MnB) and a Cumulative Exposure Index (CEI) based on Mn-air, duration and type of welding. Welders performed a mean of 16.5 months of welding on the bridge, were on average 43.8 years of age and had on average 12.6 years of education. RESULTS: The mean time weighted average of Mn-air ranged from 0.11-0.46 mg/m(3) (55% >0.20 mg/m(3)). MnB >10 microg/l was found in 43% of the workers, but the concentrations of Mn in urine, lead in blood and copper and iron in plasma were normal. Forced expiratory volume at 1s: forced vital capacity ratios (FEV(1)/FVC) were found to be abnormal in 33.3% of the welders after about 1.5 years of welding at the bridge. Mean scores of bradykinesia and Unified Parkinson Disease Rating Scale exceeded 4 and 6, respectively. Computer assisted tremor analysis system hand tremor and body sway tests, and University of Pennsylvania Smell Identification Test showed impairment in 38.5/61.5, 51.4 and 88% of the welders, respectively. Significant inverse dose-effect relationships with CEI and/or MnB were found for IQ (p<or=0.05), executive function (p<or=0.03), sustaining concentration and sequencing (p<or=0.04), verbal learning (p<or=0.01), working (p<or=0.04) and immediate memory (p<or=0.02), even when adjusted for demographics and years of welding before Bay Bridge. Symptoms reported by the welders while working were: tremors (41.9%); numbness (60.5%); excessive fatigue (65.1%); sleep disturbance (79.1%); sexual dysfunction (58.1%); toxic hallucinations (18.6%); depression (53.5%); and anxiety (39.5%). Dose-effect associations between CEI and sexual function (p<0.05), fatigue (p<0.05), depression (p<0.01) and headache (p<0.05) were statistically significant. CONCLUSIONS: Confined space welding was shown to be associated with neurological, neuropsychological and pulmonary adverse health effects. A careful enquiry of occupational histories is recommended for all welders presenting with neurological or pulmonary complaints, and a more stringent prevention strategy should be considered for Mn exposure due to inhalation of welding fume.
BACKGROUND: Although adverse neuropsychological and neurological health effects are well known among workers with high manganese (Mn) exposures in mining, ore-processing and ferroalloy production, the risks among welders with lower exposures are less well understood. METHODS: Confined space welding in construction of a new span of the San Francisco-Oakland Bay Bridge without adequate protection was studied using a multidisciplinary method to identify the dose-effect relationship between adverse health effects and Mn in air or whole blood. Bridge welders (n = 43) with little or no personal protection equipment and exposed to a welding fume containing Mn, were administered neurological, neuropsychological, neurophysiological and pulmonary tests. Outcome variables were analysed in relation to whole blood Mn (MnB) and a Cumulative Exposure Index (CEI) based on Mn-air, duration and type of welding. Welders performed a mean of 16.5 months of welding on the bridge, were on average 43.8 years of age and had on average 12.6 years of education. RESULTS: The mean time weighted average of Mn-air ranged from 0.11-0.46 mg/m(3) (55% >0.20 mg/m(3)). MnB >10 microg/l was found in 43% of the workers, but the concentrations of Mn in urine, lead in blood and copper and iron in plasma were normal. Forced expiratory volume at 1s: forced vital capacity ratios (FEV(1)/FVC) were found to be abnormal in 33.3% of the welders after about 1.5 years of welding at the bridge. Mean scores of bradykinesia and Unified Parkinson Disease Rating Scale exceeded 4 and 6, respectively. Computer assisted tremor analysis system hand tremor and body sway tests, and University of Pennsylvania Smell Identification Test showed impairment in 38.5/61.5, 51.4 and 88% of the welders, respectively. Significant inverse dose-effect relationships with CEI and/or MnB were found for IQ (p<or=0.05), executive function (p<or=0.03), sustaining concentration and sequencing (p<or=0.04), verbal learning (p<or=0.01), working (p<or=0.04) and immediate memory (p<or=0.02), even when adjusted for demographics and years of welding before Bay Bridge. Symptoms reported by the welders while working were: tremors (41.9%); numbness (60.5%); excessive fatigue (65.1%); sleep disturbance (79.1%); sexual dysfunction (58.1%); toxic hallucinations (18.6%); depression (53.5%); and anxiety (39.5%). Dose-effect associations between CEI and sexual function (p<0.05), fatigue (p<0.05), depression (p<0.01) and headache (p<0.05) were statistically significant. CONCLUSIONS: Confined space welding was shown to be associated with neurological, neuropsychological and pulmonary adverse health effects. A careful enquiry of occupational histories is recommended for all welders presenting with neurological or pulmonary complaints, and a more stringent prevention strategy should be considered for Mn exposure due to inhalation of welding fume.
Authors: Robert M Park; Rosemarie M Bowler; Donald E Eggerth; Emily Diamond; Katie J Spencer; Donald Smith; Roberto Gwiazda Journal: Neurotoxicology Date: 2005-12-05 Impact factor: 4.294
Authors: Y Kim; J W Kim; K Ito; H S Lim; H K Cheong; J Y Kim; Y C Shin; K S Kim; Y Moon Journal: Neurotoxicology Date: 1999 Apr-Jun Impact factor: 4.294
Authors: Robert O Wright; Chitra Amarasiriwardena; Alan D Woolf; Rebecca Jim; David C Bellinger Journal: Neurotoxicology Date: 2005-11-28 Impact factor: 4.294
Authors: Gail A Wasserman; Xinhua Liu; Faruque Parvez; Habibul Ahsan; Diane Levy; Pam Factor-Litvak; Jennie Kline; Alexander van Geen; Vesna Slavkovich; Nancy J LoIacono; Zhongqi Cheng; Yan Zheng; Joseph H Graziano Journal: Environ Health Perspect Date: 2006-01 Impact factor: 9.031
Authors: Alison Elder; Robert Gelein; Vanessa Silva; Tessa Feikert; Lisa Opanashuk; Janet Carter; Russell Potter; Andrew Maynard; Yasuo Ito; Jacob Finkelstein; Günter Oberdörster Journal: Environ Health Perspect Date: 2006-08 Impact factor: 9.031
Authors: Gunilla Wastensson; Gerd Sallsten; Rita Bast-Pettersen; Lars Barregard Journal: Int Arch Occup Environ Health Date: 2011-10-29 Impact factor: 3.015
Authors: Teresa Moreno; Marco Pandolfi; Xavier Querol; Javier Lavín; Andrés Alastuey; Mar Viana; Wes Gibbons Journal: Environ Sci Pollut Res Int Date: 2010-06-27 Impact factor: 4.223
Authors: Wisanti Laohaudomchok; Xihong Lin; Robert F Herrick; Shona C Fang; Jennifer M Cavallari; Ruth Shrairman; Alexander Landau; David C Christiani; Marc G Weisskopf Journal: Neurotoxicology Date: 2010-12-28 Impact factor: 4.294
Authors: Rachel R Eastman; Tom P Jursa; Chiara Benedetti; Roberto G Lucchini; Donald R Smith Journal: Environ Sci Technol Date: 2013-01-17 Impact factor: 9.028